83FR48333 (60-day notice)

Federal Register / Vol. 83, No. 185 / Monday, September 24, 2018 / Notices
Commission’s rules; any submissions
that contain BPI must also conform with
the requirements of sections 201.6,
207.3, and 207.7 of the Commission’s
rules. The Commission’s Handbook on
E-Filing, available on the Commission’s
website at https://www.usitc.gov/
secretary/documents/handbook_on_
filing_procedures.pdf, elaborates upon
the Commission’s rules with respect to
electronic filing.
In accordance with sections 201.16(c)
and 207.3 of the rules, each document
filed by a party to the investigation must
be served on all other parties to the
investigation (as identified by either the
public or BPI service list), and a
certificate of service must be timely
filed. The Secretary will not accept a
document for filing without a certificate
of service.
Authority: This investigation is being
conducted under authority of title VII of the
Tariff Act of 1930; this notice is published
pursuant to section 207.12 of the
Commission’s rules.
By order of the Commission.
Issued: September 18, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018–20655 Filed 9–21–18; 8:45 am]
BILLING CODE 7020–02–P

INTERNATIONAL TRADE
COMMISSION
[Investigation No. 332–565]

American Manufacturing
Competitiveness Act: Effects of
Temporary Duty Suspensions and
Reductions on the U.S. Economy
Proposed Information Collection;
Comment Request; and MTB Effects
Questionnaire
United States International
Trade Commission.
ACTION: Notice.
AGENCY:

In accordance with the
provisions of the Paperwork Reduction
Act of 1995, the U.S. International Trade
Commission (Commission) hereby gives
notice that it plans to submit a request
for approval of a questionnaire to the
Office of Management and Budget
(OMB) for review and requests public
comment on its draft proposed
collection.
DATES: To ensure consideration, written
comments must be submitted on or
before November 23, 2018.
ADDRESSES: The project leader for this
investigation is Kimberlie Freund.
Please direct all written comments to
[email protected] or via U.S. mail at
U.S. International Trade Commission,

amozie on DSK3GDR082PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

17:40 Sep 21, 2018

Jkt 244001

500 E Street SW, Washington, DC
20436.
Additional Information: Copies of the
draft questionnaire and other
supplementary documents may be
downloaded from the USITC website at
https://www.usitc.gov/MTBEffects. For
any questions about this notice, email
[email protected] or call the project
leader for this investigation, Kimberlie
Freund (202–708–5402). Hearingimpaired individuals may obtain
information on this matter by contacting
the Commission’s TDD terminal at 202–
205–1810. General information
concerning the Commission may also be
obtained by accessing its website
(http://www.usitc.gov).
Purpose of Information Collection:
The information requested by the
questionnaire is for use by the
Commission in connection with
preparing the report required by section
4 of the American Manufacturing
Competitiveness Act of 2016 (AMCA),
19 U.S.C. 1332 note. The Commission is
instituting Investigation No. 332–565,
American Manufacturing
Competitiveness Act: Effects of
Temporary Duty Suspensions and
Reductions on the U.S. Economy, for the
purpose of preparing this report. Section
4 of the AMCA requires the
Commission, upon enactment of a
miscellaneous tariff bill, to prepare and
submit to the House Committee on
Ways and Means and the Senate
Committee on Finance (hereinafter
Committees) a report on the effects on
the U.S. economy of duty suspensions
and reductions enacted pursuant to the
AMCA, including a broad assessment of
the economic effects of such duty
suspensions and reductions on
producers, purchasers, and consumers
in the United States, using case studies
describing such effects on selected
industries or by type of article as
available data permit. The AMCA also
requires the Commission to solicit and
append to the report recommendations
with respect to those domestic industry
sectors or specific domestic industries
that might benefit from permanent duty
suspensions and reductions, either
through a unilateral action of the United
States or through negotiations for
reciprocal tariff agreements, with a
particular focus on inequities created by
tariff inversions. As part of any such
assessment, the Commission intends to
survey U.S. firms that have successfully
petitioned for duty suspensions and
reductions and those commenting on
their petitions about the effects of these
duty suspensions and reductions on
U.S. firms. The AMCA requires the
Commission to submit its report 12

PO 00000

Frm 00060

Fmt 4703

Sfmt 4703

48333

months after enactment of a
miscellaneous tariff bill.
Summary of Proposal
(1) Number of forms submitted: 1.
(2) Title of form: American
Manufacturing Competitiveness Act:
Effects of Temporary Duty Suspensions
and Reductions on the U.S. Economy.
(3) Type of request: New.
(4) Frequency of use: Industry
questionnaire, single data gathering.
(5) Description of respondents:
Members of the public who filed
petitions with respect to products that
are the subject of a miscellaneous tariff
bill, as well as members of the public
who commented on the petitions filed.
(6) Estimated number of respondents:
750.
(7) Estimated total number of hours to
complete the questionnaire per
respondent: 2 hours.
(8) Information obtained from the
questionnaire that qualifies as
confidential business information will
be so treated by the Commission and not
disclosed in a manner that would reveal
the individual operations of a firm.
SUPPLEMENTARY INFORMATION:
I. Abstract
Section 4 of the AMCA directs the
Commission to submit to the House
Committee on Ways and Means and the
Senate Committee on Finance ‘‘a report
on the effects on the United States
economy of duty suspensions and
reductions enacted pursuant to this Act
including a broad assessment of the
economic effects of such duty
suspensions and reductions on
producers, purchasers and consumers in
the United States using case studies
describing such effects on selected
industries or by type of article as
available data permit.’’ The AMCA also
directs the Commission to solicit and
include in the report ‘‘recommendations
with respect to those domestic industry
sectors or specific domestic industries
that might benefit from permanent duty
suspensions and reductions, either
through a unilateral action of the United
States or [through] negotiations for
reciprocal tariff agreements, with a
particular focus on inequities created by
tariff inversions.’’ The questionnaire
will collect information in response to
these elements.
II. Method of Collection
Respondents will be mailed a letter
with a link and individual code for
accessing the online form. Respondents
may also request a fillable form. Once
the online form is complete,
respondents will be directed to submit
the form by selecting a submit button.

E:\FR\FM\24SEN1.SGM

24SEN1

48334

Federal Register / Vol. 83, No. 185 / Monday, September 24, 2018 / Notices

When respondents complete a fillable
form, they may submit it by uploading
it to a secure webserver, emailing it to
the study team at [email protected],
faxing it, or mailing a hard copy to the
Commission.
III. Request for Comments

they will also become a matter of public
record.
By order of the Commission.
Issued: September 18, 2018.
Lisa Barton,
Secretary to the Commission.
BILLING CODE P

DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]

Bulk Manufacturer of Controlled
Substances Application: Halo
Pharmaceutical, Inc.
ACTION:

The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 18,
2018, Halo Pharmaceutical, Inc., 30
North Jefferson Road, Whippany, New
Jersey 07981–1030 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:

SUPPLEMENTARY INFORMATION:

[FR Doc. 2018–20657 Filed 9–21–18; 8:45 am]

Comments are invited on (1) whether
the proposed collection of information
is necessary; (2) the accuracy of the
agency’s estimate of the burden
(including hours and cost) of the
proposed collection of information; (3)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
The draft questionnaire and other
supplementary documents may be
downloaded from the USITC website at
https://www.usitc.gov/MTBEffects.
Comments submitted in response to
this notice will be summarized and/or
included in the request for OMB
approval of this information collection;

Morrissette Drive, Springfield, Virginia
22152.

Notice of application.

Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 23, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
DATES:

Controlled substance

Drug code

Dihydromorphine .............................................................................................................................................................
Hydromorphone ...............................................................................................................................................................

The company plans to manufacture
Hydromorphone (9150) for distribution
to its customers. Dihydromorphine
(9145) as an intermediate in the
manufacture of Hydromorphone and is
not for commercial distribution.
Dated: September 14, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–20701 Filed 9–21–18; 8:45 am]
BILLING CODE 4410–09–P

Drug Enforcement Administration
[Docket No. DEA–392]

Bulk Manufacturer of Controlled
Substances Application: AMPAC Fine
Chemicals Virginia, LLC
amozie on DSK3GDR082PROD with NOTICES1

The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,

SUPPLEMENTARY INFORMATION:

DEPARTMENT OF JUSTICE

ACTION:

Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before November 23, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:

Notice of application.

Drug code

Phenylacetone .................................................................................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................

17:40 Sep 21, 2018

Jkt 244001

PO 00000

Frm 00061

Fmt 4703

Sfmt 4703

I
II

importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on April
19, 2018, AMPAC Fine Chemicals
Virginia, LLC, 2820 North Normandy
Drive, Petersburg, Virginia 23805–2380
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:

Controlled substance

VerDate Sep<11>2014

9145
9150

Schedule

E:\FR\FM\24SEN1.SGM

24SEN1

8501
9300
9333
9668

Schedule
II
II
II
II